Dr. Philip J. Bergman is the Director of Clinical Studies for VCA. He is the principal veterinary investigator for the fully licensed canine melanoma vaccine (Oncept). Dr. Bergman is an adjunct faculty member of
the Memorial Sloan Kettering Cancer Center. Before Dr. Bergman joined VCA, he served as the Chief Medical Officer for BrightHeart Veterinary Centers from July 2007 to August 2011; from 1999 to June 2007, he was the head of the Donaldson-Atwood Cancer Center at AMC. After finishing veterinary school at Colorado State in 1990, he was an intern at Kansas State (1990–1991) and returned to CSU for his medical oncology residency (1991–1994). He then completed a PhD fellowship in human cancer biology at the M.D. Anderson Cancer Center in Houston (1994–1999). He was previously Chair of the ACVIM Board of Regents and President of the Veterinary Cancer Society. Dr. Bergman has been a veterinary oncologist at Katonah Bedford Veterinary Center since 2007. His skills and expertise include clinical oncology, cancer biology, small animals, medical oncology, tumor biology, molecular oncology, cancer immunology, and translational medicine.
Dr. Philip J. Bergman is the Director of Clinical Studies for VCA. He is the principal veterinary investigator for the fully licensed canine melanoma vaccine (Oncept). Dr. Bergman is an adjunct faculty member of
the Memorial Sloan Kettering Cancer Center. Before Dr. Bergman joined VCA, he served as the Chief Medical Officer for BrightHeart Veterinary Centers from July 2007 to August 2011; from 1999 to June 2007, he was the head of the Donaldson-Atwood Cancer Center at AMC. After finishing veterinary school at Colorado State in 1990, he was an intern at Kansas State (1990–1991) and returned to CSU for his medical oncology residency (1991–1994). He then completed a PhD fellowship in human cancer biology at the M.D. Anderson Cancer Center in Houston (1994–1999). He was previously Chair of the ACVIM Board of Regents and President of the Veterinary Cancer Society. Dr. Bergman has been a veterinary oncologist at Katonah Bedford Veterinary Center since 2007. His skills and expertise include clinical oncology, cancer biology, small animals, medical oncology, tumor biology, molecular oncology, cancer immunology, and translational medicine.